Possible scenario
Security Scare Cycle
20% Chance
The market and policymakers focus less on the drug-design achievement and more on the implication that AI-generated pathogens are now credible planning assumptions. This produces a modest risk-off tone, offset by higher perceived demand for diagnostics, surveillance, and countermeasure firms.
Initial impacts
- Riskier companies' borrowing costs Up
- Market volatility Up
Secondary impacts
- Technology -0.5%
- Healthcare +0.1%
Tickers
- +3.8%
Portfolio impact
S&P 500-0.3%
Each figure is the modeled move of the S&P 500 if the outcome occurs. For information only. Not investment advice.
Keeping an eye on this scenario?
Tilt can alert you when its probability or impact shifts, or send you a recommendation when it crosses a threshold.